Katie Stamp PhD
About Katie Stamp PhD
Katie Stamp, PhD, is the Scientific Director of Toxicology at Bristol Myers Squibb in New Jersey, with over 15 years of experience in toxicology research and development.
Current Role at Bristol Myers Squibb
Katie Stamp, PhD, is currently serving as the Scientific Director of Toxicology at Bristol Myers Squibb in New Jersey, United States. In this role, she oversees toxicology research and development projects, contributing to the organization's advancements in this critical field.
Career Progression at Bristol Myers Squibb
Katie Stamp joined Bristol Myers Squibb in 2019 as a Sr Principal Scientist in Toxicology. She advanced to the position of Scientific Associate Director in 2020 and was promoted to her current role as Scientific Director of Toxicology. Her ascent within the company highlights her expertise and dedication to toxicology research.
Past Roles at Celgene
Katie Stamp worked at Celgene in various roles related to toxicology. She started as a Technical Writer in 2015, progressed to Senior Writer, then Principal Scientist, and finally Sr Principal Scientist. Her progression at Celgene was marked by increasing responsibilities and a focus on both technical and senior writing within toxicology.
Experience at AstraZeneca R&D
Before joining Celgene, Katie Stamp worked for six years as a Project Toxicologist at AstraZeneca R&D in Alderley Edge, Cheshire, UK. During her tenure, she contributed to multiple toxicology research initiatives, enhancing her experience in the field of toxicology.
Academic Background and Early Career
Katie Stamp has a robust educational background, earning a Doctor of Philosophy (PhD) in Toxicology and a Master of Science (MSc) from The University of Manchester, and a Bachelor's Degree from Durham University. She began her career as a Postdoctoral Researcher at The University of Manchester before transitioning to industry roles.